A study compared serum and CSF levels of C5a and terminal complement complex (TCC) in 21 newly diagnosed, treatment-naïve CIDP patients, with that of 29 control patients with noninflammatory neurological diseases. Here, C5 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.